TCGA data showed that lower expression of adipocyte-related markers, like FABP4, adiponectin, perilipin1, and perilpin5, was associated with worse survival outcomes of breast cancer (Supplementary Fig. S6). Here, ADIPOQ is linked to breast carcinoma.